Schiffmann, S.; Gunne, S.; Ulshöfer, T.; Henke, M.; Roser, L.A.; Schneider, A.-K.; Cinatl, J.; Thomas, D.; Schreiber, Y.; Wagner, P.V.;
et al. In Vitro Safety, Off-Target and Bioavailability Profile of the Antiviral Compound Silvestrol. Pharmaceuticals 2022, 15, 1086.
https://doi.org/10.3390/ph15091086
AMA Style
Schiffmann S, Gunne S, Ulshöfer T, Henke M, Roser LA, Schneider A-K, Cinatl J, Thomas D, Schreiber Y, Wagner PV,
et al. In Vitro Safety, Off-Target and Bioavailability Profile of the Antiviral Compound Silvestrol. Pharmaceuticals. 2022; 15(9):1086.
https://doi.org/10.3390/ph15091086
Chicago/Turabian Style
Schiffmann, Susanne, Sandra Gunne, Thomas Ulshöfer, Marina Henke, Luise A. Roser, Ann-Kathrin Schneider, Jindrich Cinatl, Dominique Thomas, Yannick Schreiber, Pia Viktoria Wagner,
and et al. 2022. "In Vitro Safety, Off-Target and Bioavailability Profile of the Antiviral Compound Silvestrol" Pharmaceuticals 15, no. 9: 1086.
https://doi.org/10.3390/ph15091086
APA Style
Schiffmann, S., Gunne, S., Ulshöfer, T., Henke, M., Roser, L. A., Schneider, A. -K., Cinatl, J., Thomas, D., Schreiber, Y., Wagner, P. V., Grünweller, A., & Parnham, M. J.
(2022). In Vitro Safety, Off-Target and Bioavailability Profile of the Antiviral Compound Silvestrol. Pharmaceuticals, 15(9), 1086.
https://doi.org/10.3390/ph15091086